Picture of Insight Molecular Diagnostics logo

IMDX — Insight Molecular Diagnostics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Oncocyte And Bio-Rad Partner On Global Launch Of Transplant Assay

April 11 (Reuters) - Oncocyte Corp  OCX.O :
    * ONCOCYTE AND BIO-RAD PARTNER ON GLOBAL LAUNCH OF
TRANSPLANT
ASSAY
    * ONCOCYTE CORP - BIO-RAD HAS BEEN GRANTED AN OPTION FOR IVD
COMMERCIAL RIGHTS AT FDA CLEARANCE, SUBJECT TO MEETING SPECIFIC
OBJECTIVES
    * ONCOCYTE CORP - BIO-RAD EXPECTS TO MAKE EQUITY INVESTMENT
IN
SUPPORT OF DEAL
    * ONCOCYTE CORP - BIO-RAD AND ONCOCYTE WILL CO-MARKET ASSAY
INSIDE
US AND GERMANY, WITH ONCOCYTE ACTING AS COMMERCIAL LEAD

Source text for Eikon:  ID:nGNX40yr7L 
Further company coverage:  OCX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Insight Molecular Diagnostics

See all news